NEUROMODULATORY DEVICES & APPLICATIONS (NMDA), INC

Ampa Health is a neurotechnology company developing transcranial magnetic stimulation (TMS) systems for treating depression, anxiety, PTSD, and other neurological and mental health disorders. The flagship Ampa One platform delivers accelerated TMS using Synchronized Neuromodulation Therapy (SNT), enabling significantly shorter treatment protocols—potentially one-day treatment—while maintaining clinical efficacy. Clinical data demonstrates 72% remission rates for depression within three months. The system is designed for clinical accessibility, portability, and scalability, with telemedicine capabilities for remote treatment delivery. Ampa targets healthcare providers and mental health facilities seeking evidence-based, efficient neuromodulation solutions to expand treatment capacity and improve patient access to care.